ARCHIVED - Investing In Prevention - The Economic Perspective

 

6. References

Adams J, White M. “When the population approach to prevention puts the health of individuals at risk.” International Journal of Epidemiology 2005;34:40-43.

Anderson R. “Systematic reviews of economic evaluations: utility or futility?” Health Economics 2009;DOI 10.1002/hec.1486 (published online 20 April 2009 in advance of print).

Ashenbaum B. “Defining cost reduction and cost avoidance.” CAPS Research Critical Issues Report, March 2006.

Bartik, TJ. “The economic development benefits of universal preschool education compared to traditional economic development programs.” (Report to the Committee for Economic Development), 2006. Available at http://www.upjohninst.org/preschool/short_report.pdf, accessed 27 February 2009.

Bloom DE, Canning D. “The health and wealth of nations.” Science 2000;287(5456):1207-1209.

Brisson M, Van de Velde N, De Wals P, Boily MC. “The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada.” Vaccine 2007;25:5399-5408.

Burnet DL, Elliott LD, Quinn MT, Plaut AJ, Schwartz MA, Chin MH. “Preventing diabetes in the clinical setting.” Journal of General Internal Medicine 2006;21:84-93.

Butler-Jones D. The Chief Public Health Officer’s Report on the State of Public Health in Canada, 2008. Ottawa: Her Majesty the Queen in Right of Canada, 2008.

CCS/NCIC (Canadian Cancer Society/National Cancer Institute of Canada). Canadian Cancer Statistics 2008. Toronto: CCS/NCIC, 2008.

CCS/NCIC (Canadian Cancer Society/National Cancer Institute of Canada). Canadian Cancer Statistics 2006. Toronto: CCS/NCIC, 2006.

CDC (Centers for Disease Control and Prevention). “Achievements in public health, 1900-1999 impact of vaccines universally recommended for children—United States, 1990-1998.” Mortality and Morbidity Weekly Report 1999;48(12):243-248.

CIC (Canadian Immunization Committee). Recommendations on a Human Papillomavirus Vaccination Program. Ottawa: Her Majesty the Queen in Right of Canada, 2008.

Carande-Kulis VG, Maciosek MV, Briss PA, Teutsch SM, Zaza S, Truman BI, Messonnier ML, Pappaioanou M, Harris JR, Fielding J; Task Force on Community Preventive Services. “Methods for systematic reviews of economic evaluations for the Guide to Community Preventive Services.” American Journal of Preventive Medicine 2000;18(S1):75-91.

CRD (Centre for Reviews and Dissemination). Systematic Reviews: CRD’s Guidance for Undertaking Reviews in Health Care. York, UK: CRD, 2008.

Chiou CF, Hay JW, Wallace JF, Bloom BS, Neumann PJ, Sullivan SD, Yu HT, Keeler EB, Henning JM, Ofman JJ. “Development and validation of a grading system for the quality of cost-effectiveness studies.” Medical Care 2003;41(1):32-44.

Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, Atkins D, Richland JH, Haddix A. “Priorities among recommended clinical preventive services.” American Journal of Preventive Medicine 2001;21:1-9.

Cohen DA, Wu SY, and Farley TA. “Comparing the cost-effectiveness of HIV prevention interventions.” Journal of Acquired Immune Deficiency Syndromes 2004;37(3):1404-1414.

Cohen JT, Neumann PT, and Weinstein MC. “Does preventive care save money? Health economics and the presidential candidates.” New England Journal of Medicine 2008;358(7):661-663

Commission on Social Determinants of Health. Closing the Gap in a Generation: Health Equity Through Action on the Social Determinants of Health. Final Report of the Commission on Social Determinants of Health. Geneva: World Health Organization, 2008.

Dalziel K, Segal L. “Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions.” Health Promotion International 2007;22(4):271-283.

Delahanty LM, Nathan DM. “Implications of the Diabetes Prevention Program and Look AHEAD Clinical Trials for Lifestyle Interventions.” Journal of the American Dietetic Association 2008;108(4Suppl1):S66-S72.

Delgado C. “Evaluation of needle exchange programs.” Public Health Nursing 2004;21(2):171-178.

Department of Human Services (State Government of Victoria, Australia). ACE-Obesity: Assessing Cost-Effectiveness of Obesity Interventions in Children and Adolescents—Summary of Results. Melbourne: State of Victoria, 2006.

Diamant AL, Schuster MA, Lever J. “Receipt of preventive health care services by lesbians.” American Journal of Preventive Medicine 2000;19(3):141-148.

Dishman RK, Sallis JF, Orenstein DR. “The determinants of physical activity and exercise.” Public Health Reports 1985;100(2):158–171.

Dooris M, Poland B, Kolbe L, de Leeuw E, McCall D, Wharf-Higgins J. “Healthy settings: building evidence for the effectiveness of whole system health promotion—challenges and future directions.” In McQueen D, Jones C (Eds), Global Perspectives on Health Promotion Effectiveness. NY: Springer.

Doubilet P, Weinstein MC, McNeil BJ. “Use and misuse of the term ‘cost effective’ in medicine.” New England Journal of Medicine 1986;314:253-256.

Dow W, Schoeni RF. Economic Value of Improving the Health of Disadvantaged Americans [technical report for Overcoming Obstacles to Health, Report from the Robert Wood Johnson Foundation to the Commission to Build a Healthier America], 2008. Available at http://www.commissiononhealth.org/Publications.aspx, accessed 2 March 2009.

Drummond MF, Sculper MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes (3rd ed.). Oxford: Oxford University Press, 2005.

Fichtenberg CM, Glantz SA. “Effect of smoke-free workplaces on smoking behaviour: systematic review.” British Medical Journal 2002;325:188-194

Flanagan WM, LePetit CL, Berthelot JM, White KJ, Coombs BA, Jones-McLean E. “Potential impact of population-based colorectal cancer screening in Canada.” Chronic Disease in Canada 2003:24(4);81-88.

Frick KD, Jones AS. “Gender bias in economic evaluation methods: quality of life and family role effects.” Women’s Health Issues 2008;18:4-6.

Goldsmith LJ, Hutchinson B, Hurley J. Economic Evaluation Across the Four Faces of Prevention: A Canadian Perspective. Centre for Health Economics and Policy Analysis, Working Paper 06-01, 2004.

Graham JD, Thompson KM, Goldie SJ, Segui-Gomez M, and Weinstein MC. “The cost-effectiveness of air bags by seating position.” Journal of the American Medical Association 1997;278(17):1418-1425.

Grosse SD. “Does newborn screening save money? The difference between cost-effective and cost-saving interventions.” Journal of Pediatrics 2005;146:168-170.

Grosse SD, Teutsch SM, Haddix AC. “Lessons from cost-effectiveness research for United States public health policy.” Annual Review of Public Health 2007;28:365-391.

H. Krueger and Associates. “Establishing priorities among effective clinical prevention services in British Columbia: summary and technical report” (unpublished report prepared for the BC Clinical Prevention Policy Review Committee), 2008a.

H. Krueger and Associates. “Implementing a human papillomavirus vaccination program: evidence on cost-effectiveness,” 2008b. Available at http://www.krueger.ca, accessed 18 March 2009.

Hagberg LA, Lindholm L. “Is promotion of physical activity a wise use of societal resources? Issues of cost-effectiveness and equity in health.” Scandinavian Journal of Medicine and Science in Sports 2005;15:304-312.

Hankivsky O, Friesen J, Varcoe C, MacPhail F, Greaves L, Spencer C. “Expanding economic costing in health care: values, gender and diversity.” Canadian Public Policy 2004;30(3):257-282.

Hawthorne K, Robles Y, Cannings-John R, Edwards AGK. “Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups.” Cochrane Database of Systematic Reviews 2008;Issue 3.

Hayee BH, Chung-Faye G. “Colorectal cancer screening.” Clinical Medicine 2006;6(5):453-456.

Health Canada. Economic Burden of Illness in Canada 1998. Ottawa: Minister of Public Works and Government Services Canada, 2002.

Health Disparities Task Group, Federal/Provincial/Territorial Advisory Committee on Population Health and Health Security. Reducing Health Disparities—Roles of the Health Sector: Discussion Paper (December 2004), 2005. Available at http://www.phac-aspc.gc.ca/ph-sp/disparities/pdf06/disparities_discussion_paper_e.pdf, accessed 29 April 2009.

Herbst JH, Beeker C, Mathew A, McNally T, Passin W, Kay L, Crepaz N, Lyles C, Briss P, Chattopadhyay S, Johnson RL; Task Force on Community Preventive Services. “The effectiveness of individual-, group-, and community-level HIV behavioral risk-reduction interventions for adult men who have sex with men: a systematic review.” American Journal of Preventive Medicine 2007;32(4):38-67.

Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group. “The cost-effectiveness of lifestyle modification or Metformin in preventing Type 2 diabetes in adults with impaired glucose tolerance.” Annals of Internal Medicine 2005;142:323-332.

IHE (Institute of Health Economics). IHE in your Pocket 2008: A Handbook of Health Economic Statistics. Edmonton: IHE, 2008.

Jones AS, Frick KD. “Gender bias in economic evaluation methods: time costs and productivity loss.” Women’s Health Issues 2008;18:1-3.

Karoly L, Kilburn MR, Cannon J. Early Childhood Interventions: Proven Results, Future Promise. Santa Monica: RAND Corporation, 2005.

Kelly MP, McDaid D, Ludbrook A, Powell J. “Economic appraisal of public health interventions” [NHS briefing paper]. Available at www.nice.org.uk/page.aspx?o=513210, accessed 17 March 2009.

Kim JJ, Goldie SJ. “Health and economic implications of HPV vaccination in the United States.” New England Journal of Medicine 2008;359(8):821-832.

Lemstra M, Neudorf C, Mackenbach J, Nannapaneni U. “High healthcare utilization and costs associated with lower socioeconomic status: results from a linked dataset.” In Lemstra M, Neudorf C (eds.), Health Disparity in Saskatoon: Analysis to Intervention, pp. 214-224. Saskatoon: Saskatoon Health Region, 2008.

Lightwood JM, Glantz SA. “Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke.” Circulation 1997;96:1089-1096.

Lightwood JM, Phibbs CS, Glantz SA. “Short-term health and economic benefits of smoking cessation: low birth weight.” Pediatrics 1999;104(6):1312-1320.

Lorant V, Boland B, Humblet P, Deliège D. “Equity in prevention and health care.” Journal of Epidemiology and Community Health 2002;56:510-516.

Lynch JW, Kaplan GA, Salonen JT. “Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stages of the socioeconomic lifecourse.” Social Science and Medicine 1997;44(6):809-819.

Lynch RG. Exceptional Returns: Economic, Fiscal, and Social Benefits of Investment in Early Childhood Development. Washington DC: Economic Policy Institute, 2004.

Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. “Priorities among effective clinical preventive services: results of a systematic review and analysis.” American Journal of Preventive Medicine 2006a;31(1):52-61.

Maciosek MV, Solberg LI, Coffield AB, Edwards NM, Goodman MJ. “Influenza vaccination: health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.” American Journal of Preventive Medicine 2006b;31(1):72-79.

Mackenbach JP, Meerding WJ, Kunst AE.  Economic Implications of Socio-economic Inequalities in Health in the European Union. European Commission Health and Consumer Protection Directorate-General, 2007.

Marra F, Gunther O, Ogilvie G, Marra CA, Pourbohloul B, Ehlen T, Miller D, Naus M, Patrick DM, Brunham RC. A dynamic model to determine cost effectiveness of HPV vaccine in girls and boys in Canada. ISSTDR, Seattle, Washington, July 29th – August 1st, 2007.

Marrett LD, De P, Airia P, Dryer D; Steering Committee of Canadian Cancer Statistics 2008. “Cancer in Canada in 2008.” Canadian Medical Association Journal 2008;179(11):1163-1170.

Meltzer DO, Huang ES, Zhang Q, Brown S. “Effects of patient self-selection on cost-effectiveness of diabetes therapy by age.” iHEA 2007 6th World Congress: Explorations in Health Economics Paper, 2002.

Moher M, Hey K, Lancaster T. “Workplace interventions for smoking cessation.” Cochrane Database of Systematic Reviews 2005;Issue 2.

Morris SK, Nguyen CK. “The human papillomavirus vaccine in Canada.” Canadian Journal of Public Health 2008;99(2):114-116.

Mudarri DH. “The costs and benefits of smoking restrictions: an assessment of the Smoke-Free Environment Act of 1993” (H.R. 3434). Government Document 1994; H.R. 3434, April 1994.

NACI (National Advisory Committee on Immunization). “Statement on human papillomavirus vaccine.” Canada Communication Disease Report 2007;33(ACS-2):1-32.

Ong MK, Glantz SA. “Free nicotine replacement therapy programs vs implementing smoke-free workplaces: a cost-effectiveness comparison.” American Journal of Public Health 2005;95(6):969-975.

Ortega-Sanchez IR, Lee GM, Jacobs RJ, Prosser LA, Molinari NA, Zhang X, Baine WB, McCauley MM, Miller T; Working Group on Leading Economic Issues for New Vaccine for Adolescents. Pediatrics 2008;121(S1):S63-S78.

Newall AT, Beutels P, Wood JG, Edmunds WJ, MacIntyre CR. “Cost-effectiveness analyses of human papillomavirus vaccination.” Lancet Infectious Disease 2007;7:289-296.Neumann PJ. Using Cost-Effectiveness Analysis to Improve Health Care. New York: Oxford University Press, 2005.

Partnership for Prevention. What Policymakers Need to Know About Cost Effectiveness. Washington DC: Partnership for Prevention, 2001.

PHAC (Public Health Agency of Canada). “Immunization: the most successful public health measure” [website], n.d. Available at http://www.phac-aspc.gc.ca/im/measure-intervention-eng.php, accessed 28 February 2009.

PHAC (Public Health Agency of Canada). Report from the National Diabetes Surveillance System: Diabetes in Canada, 2008. Ottawa: Her Majesty the Queen in Right Canada, 2008.

PHAC (Public Health Agency of Canada). Economic Burden of Illness in Canada, 2000 [internal data].

Pomerleau J, Lock K, Knai C, McKee M. “Interventions designed to increase adult fruit and vegetable intake can be effective: a systematic review of the literature.” Journal of Nutrition 2005;135(10):2486-2495.

Priest N, Armstrong R, Doyle J, Waters E. “Interventions implemented through sporting organisations for increasing participation in sport.” Cochrane Database of Systematic Reviews 2008;Issue 3.

RWJF (Robert Woods Johnson Foundation). Overcoming Obstacles to Health: Report from the Robert Wood Johnson Foundation to the Commission to Build a Healthier America. Washington DC: RWJF, 2008.

Ramsey SD. “Methods for reviewing economic evaluations of community preventive services: a cart without a horse?” American Journal of Preventive Medicine 2000;18(S1):15-17.

Rasch A, Greiner W. “Cost-effectiveness of smoking prevention measures in adolescents.” Journal of Public Health 2008;16:3-11.

Reid D. “Failure of an intervention to stop teenagers smoking: not such a disappointment as it appears.” British Medical Journal 1999;319:934–935.

Roux L, Pratt M, Tengs TO, Yore MM, Yanagawa TL, Van Den Bos J, Rutt C, Brownson RC, Powell KE, Heath G, Kohl HW III, Teutsch S, Cawley J, Lee IM, West L, Buchner DM. “Cost effectiveness of community-based physical activity interventions.” American Journal of Preventive Medicine 2008;35(6):578-588.

Rush B, Shiell A, and Hawe P. “A census of economic evaluations in health promotion.” Health Education Research 2004;19(6):707-719.

Russell LB. Prevention’s Potential for Slowing the Growth of Medical Spending. Washington DC: National Coalition on Health Care, 2007.

Russell LB. Is Prevention Better Than Cure? Washington DC: Brookings, 1986.

Rychetnik L, Frommer M, Hawe P, Shiell A. ”Criteria for evaluating evidence on public health interventions.” Journal of Epidemiology and Community Health 2002;56:119-127.

Saha S, Hoerger TJ, Pignone MP, Teutsch SM, Helfand M, Mandelblatt JS; Cost Work Group of the Third US Preventive Services Task Force. “The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.” American Journal of Preventive Medicine 2001;20(3S):36-43.

Sassi F, Archard L, McDaid D. “Searching literature databases for health care economic evaluations: how systematic can we afford to be?” Medical Care 2002;40(5):387-394.

Schweinhart LJ. The High/Scope Perry Preschool Study Through Age 40: Summary, Conclusions, and Frequently Asked Questions. Ypsilanti, MI: High/Scope Educational Research Foundation, 2005.

Sculpher M, Pang F, Manca A, Drummond M, Golder S, Urdahl H, Davies L, Eastwood A. “Generalisability in economic evaluation studies in healthcare: a review and case studies.” Health Technology Assessment 2004;8(49).

Shiell A. “In search of social value.” International Journal of Public Health 2007;52:333-334. Shiell A, Hawe P. “Health promotion community development and the tyranny of individualism.” Health Economics 1996;5:241-247.

Shiell A, Hawe P, Gold L. “Complex interventions or complex systems? Implications for health economic evaluation.” British Medical Journal 2008;336:1281-1283.

Shiell A, McIntosh K. “Some economics of health promotion: what we know, don’t know and need to know before spending to promote public health.” Harvard Health Policy Review 2006;7(2):21-31.

Solberg LI, Maciosek MV, Edwards NM, Khanchandani HS, Goodman MJ. “Repeated tobacco-use screening and intervention in clinical practice: health impact and cost effectiveness.” American Journal of Preventive Medicine 2006;31(1): 62-71.

Stein, JG. The Cult of Efficiency. Toronto: House of Anansi, 2001.

Suhrcke M, Sauto Arce R, McKee M, Rocco L. Economic Costs of Ill Health in the European Region. Geneva: World Health Organization, 2008.

Suhrcke M, Urban D, Iburg KM, Schwappach D, Boluarte T, McKee M. The economic benefits of health and prevention in a high-income country: the example of Germany. Berlin: Veröffentlichungsreihe der Forschungsgruppe Public Health, 2007.

Suhrcke M, McKee M, Stuckler D, Sauto Arce R, Tsolova S, Mortensen J. “The contribution of health to the economy in the European Union.” Public Health 2006;120(11):994-1001.

Task Force on Community Preventive Services. “The Guide to Community Preventive Services: Task Force Findings”[website]. Available at http://www.thecommunityguide.org, accessed 28 April 2009.

Tjepkema M. “Health care use among gay, lesbian, and bisexual Canadians.” Health Reports 2008;19(1):53-64.

van Baal PHM, Polder JJ,  de Wit GA, Hoogenveen RT, Feenstra TL, Boshuizen HC, Engelfriet PM, Brouwer WBF. “Lifetime medical costs of obesity: prevention no cure for increasing health expenditure.” PLoS Medicine 2008;5(2):e29.

Vijgen SM, Hoogendoorn M, Baan CA, de Wit GA, Limburg W, Feenstra TL. “Cost effectiveness of preventive interventions in type 2 diabetes mellitus: a systematic literature review.” Pharmaeconomics 2006;24(5):425-441.

Waddell C, Hua JM, Garland OM, Peters RD, McEwan K. “Preventing mental disorders in children: a systematic review to inform policy-making.” Canadian Journal of Public Health 2007;98(3):166-173.

Wall J, Mhurchu CN, Blakely T, Rodgers A, Wilton J. “Effectiveness of monetary incentives in modifying dietary behavior: a review of randomized, controlled trials.” Nutrition Reviews 2006;64(12):518-531.

Wanless D. Securing Good Health for the Whole Population: Final Report. London: HM Treasury, 2004.

Weinstein MC, Siegel JE, Gold MR, Kamlet MS, and Russell LB. “Recommendations of the Panel on Cost-Effectiveness in Health and Medicine.” Journal of the American Medical Association 1996;276(15):1253-1258.

Welte R, Feenstra T, Jager H, Leidl R. “A decision chart for assessing and improving the transferability of economic evaluation results between countries.” Pharmacoeconomics 2004;22(13):857-876.

Williams DR, Costa MV, Odunlami AO, Mohammed SA. “Moving upstream: how interventions that address the social determinants of health can improve health and reduce disparities.” Journal of Public Health Management and Practice 2008;14(Suppl.):S8-S17.

Wodak A, Cooney A. “Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.” Substance Use and Misuse 2006;41:777-813.

Woolf SH, Husten CG, Lewin LS, Marks JE, Fielding JE, Sanchez EJ. “The economic argument for disease prevention: distinguishing between value and savings.” [Policy paper prepared for the National Commission on Prevention Priorities, Partnership for Prevention], 2009.

Woolf SH. “The power of prevention and what it requires.” Journal of the American Medical Association 2008;299(20):2437-2439.

WCRF/AICR (World Cancer Research Fund/American Institute for Cancer Research). Policy and Action for Cancer Prevention. Food, Nutrition, and Physical Activity: a Global Perspective. Washington DC: AICR, 2009.

WHO (World Health Organization). Ottawa Charter for Health Promotion [WHO document no. WHO/HPR/HEP/95.1].  WHO: Geneva, 1986.

Zechmeister I, Kilian R, McDaid M, the MHEEN group. “Is it worth investing in mental health promotion and prevention of mental illness? A systematic review of the evidence from economic evaluations.” BMC Public Health 2008;8:20.

Zhou F, Santoni F, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R. “Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.” Archives of Pediatrics and Adolescent Medicine 2005;159:1136–1144.

Page details

Date modified: